{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:12:52Z","timestamp":1759515172894,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4567-3","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T12:07:41Z","timestamp":1528373261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-8291","authenticated-orcid":false,"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Agander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrid","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik Otzen","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn Cilius","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4567_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2016.10.015","volume":"70","author":"A-LF Carlander","year":"2017","unstructured":"Carlander A-LF, Gr\u00f8nh\u00f8j Larsen C, Jensen DH, Garn\u00e6s E, Kiss K, Andersen L, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75\u201382.","journal-title":"Eur J Cancer"},{"key":"4567_CR2","doi-asserted-by":"crossref","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","DOI":"10.1002\/ijc.29210"},{"key":"4567_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2016.04.004","volume":"58","author":"CN Saber","year":"2016","unstructured":"Saber CN, Gr\u00f8nh\u00f8j Larsen C, Dalianis T, von Buchwald C. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: review of the literature. Oral Oncol. 2016;58:8\u201313. Elsevier Ltd","journal-title":"Oral Oncol"},{"key":"4567_CR4","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nh\u00f8j Larsen C, Jensen DH, Carlander A-LF, Kiss K, Andersen L, Olsen CH, et al. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget. 2016;7(44):71761\u201371772.","DOI":"10.18632\/oncotarget.12335"},{"key":"4567_CR5","doi-asserted-by":"crossref","unstructured":"Garnaes E, Frederiksen K, Kiss K, Andersen L, Therkildsen MH, Franzmann MB, et al. Double positivity for HPV DNA\/p16 in tonsillar and base of tongue cancer improves prognostication: insights from a large population-based study. Int J Cancer. 2016;139(11):2598\u2013605.","DOI":"10.1002\/ijc.30389"},{"key":"4567_CR6","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1038\/modpathol.2016.152","volume":"30","author":"JS Lewis","year":"2017","unstructured":"Lewis JS. Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma: Catch Me If You Can! Mod Pathol. 2017;30:S44\u201353. Nature Publishing Group. Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2016.152 . [cited 2 June 2017]","journal-title":"Mod Pathol"},{"key":"4567_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/gm453","volume":"5","author":"M Lechner","year":"2013","unstructured":"Lechner M, Frampton GM, Fenton T, Feber A, Palmer G, Jay A, et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med. 2013;5:49. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23718828","journal-title":"Genome Med"},{"key":"4567_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ijrobp.2015.12.022","volume":"94","author":"JP Zevallos","year":"2016","unstructured":"Zevallos JP, Yim E, Brennan P, Liu AY, Taylor JM, Weissler M, et al. Molecular Profile of Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma Stratified by Smoking Status. Int J Radiat Oncol. 2016;94:864. Elsevier. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615268605 . [cited 14 June 2017]","journal-title":"Int J Radiat Oncol"},{"key":"4567_CR9","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","volume":"21","author":"TY Seiwert","year":"2015","unstructured":"Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015;21:632\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25056374 . [cited 16 June 2017]","journal-title":"Clin Cancer Res"},{"key":"4567_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"MS Lawrence","year":"2015","unstructured":"Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576\u201382. Nature Publishing Group. Available from: http:\/\/www.nature.com\/nature\/journal\/v517\/n7536\/full\/nature14129.html#supplementary-information . [cited 28 Jan 2015]","journal-title":"Nature"},{"key":"4567_CR11","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1200\/JCO.2015.62.1086","volume":"33","author":"DN Hayes","year":"2015","unstructured":"Hayes DN, Van Waes C, Seiwert TY. Genetic landscape of human papillomavirus-associated head and neck Cancer and comparison to tobacco-related tumors. J Clin Oncol. 2015;33:3227\u201334.","journal-title":"J Clin Oncol"},{"key":"4567_CR12","doi-asserted-by":"crossref","unstructured":"Saloura V, Vokes EE. EGFR-based bioradiotherapy in SCCHN. Lancet Oncol. 2015;16(2)129\u201330.","DOI":"10.1016\/S1470-2045(15)70006-9"},{"key":"4567_CR13","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1200\/JCO.2010.30.6423","volume":"28","author":"A Argiris","year":"2010","unstructured":"Argiris A, Heron DE, Smith RP, Kim S, Gibson MK, Lai SY, et al. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol. 2010;28:5294\u2013300.","journal-title":"J Clin Oncol"},{"key":"4567_CR14","doi-asserted-by":"crossref","unstructured":"Burtness B, Bauman JE, Galloway T. Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition. Lancet Oncol. 2013;14(8):e302\u20139","DOI":"10.1016\/S1470-2045(13)70085-8"},{"key":"4567_CR15","doi-asserted-by":"publisher","unstructured":"Garnaes E, Kiss K, Andersen L, Therkildsen MH, Franzmann MB, Filtenborg-Barnkob B, et al. Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. Br J Cancer. 2015;113:131\u2013134. Cancer Research UK. Available from: https:\/\/doi.org\/10.1038\/bjc.2015.198 . [cited 18 June 2015].","DOI":"10.1038\/bjc.2015.198"},{"key":"4567_CR16","doi-asserted-by":"crossref","unstructured":"Garnaes E, Kiss K, Andersen L, Therkildsen MH, Franzmann MB, Filtenborg-Barnkob B, et al. A high and increasing HPV prevalence in tonsillar cancers in eastern Denmark, 2000-2010: the largest registry-based study to date. Int J Cancer. 2015;136(9):2196\u2013203.","DOI":"10.1002\/ijc.29254"},{"key":"4567_CR17","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/bjc.2014.42","volume":"110","author":"C Gr\u00f8nh\u00f8j Larsen","year":"2014","unstructured":"Gr\u00f8nh\u00f8j Larsen C, Gyldenl\u00f8ve M, Jensen DH, Therkildsen MH, Kiss K, Norrild B, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110:1587\u201394.","journal-title":"Br J Cancer"},{"key":"4567_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333:1157\u201360.","journal-title":"Science"},{"key":"4567_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","volume":"333","author":"N Agrawal","year":"2011","unstructured":"Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154\u20137. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3162986&tool=pmcentrez&rendertype=abstract . [cited 8 Aug 2014]","journal-title":"Science"},{"key":"4567_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ccell.2015.02.007","volume":"27","author":"C Rubio-Perez","year":"2015","unstructured":"Rubio-Perez C, Tamborero D, Schroeder MP, Antol\u00edn AA, Deu-Pons J, Perez-Llamas C, et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell. 2015;27:382\u201396. Elsevier. Available from: http:\/\/www.cell.com\/article\/S1535610815000574\/fulltext . [cited 9 Mar 2015]","journal-title":"Cancer Cell"},{"key":"4567_CR21","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1373\/clinchem.2012.202390","volume":"59","author":"H Do","year":"2013","unstructured":"Do H, Wong SQ, Li J, Dobrovic A. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. Clin Chem. 2013;59:1376\u201383.","journal-title":"Clin Chem"},{"key":"4567_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.18632\/oncotarget.503","volume":"3","author":"H Do","year":"2012","unstructured":"Do H, Dobrovic A. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase. Oncotarget. 2012;3:546\u201358. Available from: http:\/\/oncotarget.com\/abstract\/503","journal-title":"Oncotarget"},{"key":"4567_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"1000 Genomes Project Consortium T 1000 GP, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23128226%5Cnhttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC3498066","journal-title":"Nature"},{"key":"4567_CR24","first-page":"23","volume":"7","author":"SQ Wong","year":"2014","unstructured":"Wong SQ, Li J, Tan AY-C, Vedururu R, Pang J-MB, Do H, et al. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genet. 2014;7:23. Available from: http:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/1755-8794-7-23 . [cited 14 June 2017]","journal-title":"BMC Med Genet"},{"key":"4567_CR25","unstructured":"Best Practices for Processing HTS Data [Internet]. Available from: http:\/\/best-practices-for-processing-hts-data.readthedocs.io\/en\/develop_mk\/mutect2_pitfalls.html%0D ."},{"key":"4567_CR26","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1002\/humu.22771","volume":"36","author":"AH Ramos","year":"2015","unstructured":"Ramos AH, Lichtenstein L, Gupta M, Lawrence MS, Pugh TJ, Saksena G, et al. Oncotator: Cancer variant annotation tool. Hum Mutat. 2015;36:E2423\u20139.","journal-title":"Hum Mutat"},{"key":"4567_CR27","doi-asserted-by":"crossref","unstructured":"Mayakonda A, Koeffler HP. Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies. BioRxiv. 2016;52662. Available from: http:\/\/www.biorxiv.org\/content\/early\/2016\/05\/11\/052662.abstract .","DOI":"10.1101\/052662"},{"key":"4567_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13059-016-0994-0","volume":"17","author":"L Mularoni","year":"2016","unstructured":"Mularoni L, Sabarinathan R, Deu-Pons J, Gonzalez-Perez A, L\u00f3pez-Bigas N. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol. 2016;17:128. Available from: http:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-016-0994-0","journal-title":"Genome Biol"},{"key":"4567_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, SAJR A, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23945592 . [cited 23 Aug 2017]","journal-title":"Nature"},{"key":"4567_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","volume":"45","author":"MB Burns","year":"2013","unstructured":"Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet. 2013;45:977\u201383. Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/ng.2701","journal-title":"Nat Genet"},{"key":"4567_CR31","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkq929","volume":"39","author":"SA Forbes","year":"2011","unstructured":"Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011;39:D945\u201350. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20952405 . [cited 6 Sept 2017]","journal-title":"Nucleic Acids Res"},{"key":"4567_CR32","doi-asserted-by":"crossref","unstructured":"Dienstmann R, Jang IS, Bot B, Friend S, Guinney J. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors. Cancer Discov. 2015;5:118\u201323. Available from: http:\/\/cancerdiscovery.aacrjournals.org\/content\/5\/2\/118 . [cited 7 July 2017].","DOI":"10.1158\/2159-8290.CD-14-1118"},{"key":"4567_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502:333\u20139. Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/nature12634","journal-title":"Nature"},{"key":"4567_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu J, Sammons MA, Donahue G, Dou Z, Vedadi M, Getlik M, et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 2015;525:206\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26331536 . [cited 2017 Jul 12]","journal-title":"Nature"},{"key":"4567_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/0194599816642436","volume":"155","author":"SF Yang","year":"2016","unstructured":"Yang SF, Bier-Laning CM, Adams W, Zilliox MJ. Candidate biomarkers for HPV-negative head and neck cancer identified via gene expression barcode analysis. Otolaryngol Neck Surg. 2016;155:416\u201322. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0194599816642436 . [cited 12 July 2017]","journal-title":"Otolaryngol Neck Surg"},{"key":"4567_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3727\/97818823455816X14760478220149","volume":"25","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang Y, Ren H, Jin Y, Guo Y. ZNRF3 inhibits the invasion and tumorigenesis in nasopharyngeal carcinoma cells by inactivating the Wnt\/\u03b2-catenin pathway. Oncol Res. 2017;25:571\u20137. Available from: http:\/\/www.ingentaconnect.com\/content\/10.3727\/97818823455816X14760478220149 . [cited 12 July 2017]","journal-title":"Oncol Res"},{"key":"4567_CR37","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/modpathol.2013.58","volume":"26","author":"F G\u00f6ke","year":"2013","unstructured":"G\u00f6ke F, Bode M, Franzen A, Kirsten R, Goltz D, G\u00f6ke A, et al. Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck. Mod. Pathol. 2013;26:1298\u2013306. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23619603 . [cited 12 July 2017]","journal-title":"Mod. Pathol"},{"key":"4567_CR38","unstructured":"von M\u00e4ssenhausen A, Franzen A, Heasley L, Perner S. FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area. Ann Transl Med. 2013;1:23. Available from: http:\/\/atm.amegroups.com\/article\/view\/2270\/3126 . [cited 12 July 2017]"},{"key":"4567_CR39","doi-asserted-by":"crossref","unstructured":"Koole K, Brunen D, van Kempen PMW, Noorlag R, de Bree R, Lieftink C, et al. FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma. Clin Cancer Res. 2016; Available from: http:\/\/clincancerres.aacrjournals.org\/content\/early\/2016\/03\/02\/1078-0432.CCR-15-1874 . [cited 23 Aug 2017]","DOI":"10.1158\/1078-0432.CCR-15-1874"},{"key":"4567_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","volume":"113","author":"R Porta","year":"2017","unstructured":"Porta R, Borea R, Coelho A, Khan S, Ara\u00fajo A, Reclusa P, et al. FGFR a promising druggable target in cancer: Molecular biology and new drugs. Crit Rev Oncol. 2017;113:256\u201367. Available from: http:\/\/www.croh-online.com\/article\/S1040-8428(17)30085-9\/pdf . [cited 23 Aug 2017]","journal-title":"Crit Rev Oncol"},{"key":"4567_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"MS Lawrence","year":"2015","unstructured":"Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25631445 . [cited 6 July 2017]","journal-title":"Nature"},{"key":"4567_CR42","doi-asserted-by":"publisher","first-page":"e77025","DOI":"10.1371\/journal.pone.0077025","volume":"8","author":"A N\u00e4sman","year":"2013","unstructured":"N\u00e4sman A, Andersson E, Marklund L, Tertipis N, Hammarstedt-Nordenvall L, Attner P, et al. HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome. PLoS One. 2013;8:e77025. Available from: http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0077025","journal-title":"PLoS One"},{"key":"4567_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.oraloncology.2006.03.003","volume":"43","author":"J Reinders","year":"2007","unstructured":"Reinders J, Rozemuller EH, Otten HG, van der Veken LTJN, Slootweg PJ, Tilanus MGJ, et al. HLA and MICA associations with head and neck squamous cell carcinoma. Oral Oncol. 2007;43:232\u201340.","journal-title":"Oral Oncol"},{"key":"4567_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.oraloncology.2017.04.017","volume":"69","author":"G Wichmann","year":"2017","unstructured":"Wichmann G, Herchenhahn C, Boehm A, Mozet C, Hofer M, Fischer M, et al. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients. Oral Oncol. 2017;69:115\u201327.","journal-title":"Oral Oncol"},{"key":"4567_CR45","doi-asserted-by":"publisher","first-page":"283ra54","DOI":"10.1126\/scitranslmed.aaa1408","volume":"7","author":"N McGranahan","year":"2015","unstructured":"McGranahan N, Favero F, de Bruin EC, Birkbak NJ, Szallasi Z, Swanton C. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med. 2015;7:283ra54. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25877892. [cited 7 July 2017]","journal-title":"Sci Transl Med"},{"key":"4567_CR46","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","volume":"7","author":"S Henderson","year":"2014","unstructured":"Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development. Cell Rep. 2014;7:1833\u201341. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124714003878 . [cited 7 July 2017]","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4567-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4567-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4567-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T05:57:53Z","timestamp":1604383073000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4567-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4567"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4567-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"13 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval is granted from the Capital Region of Denmark\u2019s regional ethics committee (ID: H-15005784). Consent to participate was waived by Capital Region of Denmark\u2019s regional ethics committee (ID: H-15005784).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"640"}}